Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
Indivior Pharmaceuticals, Inc. (INDV)
Wheadon David E. — Director
Shares
1,771
Price
$35.39
Total Value
$62.68K
Shares Held After
14,395
% of Holdings
12.3%
Actuate Therapeutics Inc (ACTU)
THOMSON TODD S — Director
Shares
280,000
Price
$5.80
Total Value
$1.62M
Shares Held After
904,795
% of Holdings
23.6%
Sight Sciences, Inc. (SGHT)
Rodberg James — Chief Financial Officer
Shares
4,405
Price
$7.82
Total Value
$34.45K
Shares Held After
154,440
% of Holdings
2.8%
Alphatec Holdings, Inc. (ATEC)
Miles Patrick — Director
Shares
100,000
Price
$21.01
Total Value
$2.10M
Shares Held After
5,135,398
% of Holdings
1.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
2,000
Price
$70.25
Total Value
$140.50K
Shares Held After
40,123
% of Holdings
4.7%
Sight Sciences, Inc. (SGHT)
HAYDEN JEREMY B. — Chief Legal Officer
Shares
9,385
Price
$7.82
Total Value
$73.39K
Shares Held After
247,205
% of Holdings
3.7%
Sight Sciences, Inc. (SGHT)
Bauerlein Alison — Chief Operating Officer
Shares
10,896
Price
$7.82
Total Value
$85.21K
Shares Held After
609,630
% of Holdings
1.8%
Xeris Biopharma Holdings, Inc. (XERS)
Shannon John Patrick Jr — Director
Shares
24,907
Price
$7.08
Total Value
$176.26K
Shares Held After
2,705,346
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$495.01
Total Value
$24.75K
Shares Held After
370
% of Holdings
11.9%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
854
Price
$95.10
Total Value
$81.22K
Shares Held After
2,281,646
% of Holdings
0.0%
ELI LILLY & Co (LLY)
LILLY ENDOWMENT INC — 10% Owner
Shares
1,390
Price
$1,085.01
Total Value
$1.51M
Shares Held After
92,189,126
% of Holdings
0.0%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
3,670
Price
$10.35
Total Value
$37.98K
Shares Held After
160,722
% of Holdings
2.2%
Apellis Pharmaceuticals, Inc. (APLS)
Baumal Caroline — Chief Medical Officer
Shares
3,020
Price
$25.53
Total Value
$77.10K
Shares Held After
91,206
% of Holdings
3.2%
MCKESSON CORP (MCK)
Rodgers Thomas L — EVP, Chief Strategy & BDO
Shares
276
Price
$816.18
Total Value
$225.27K
Shares Held After
2,268
% of Holdings
10.8%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
4,625
Price
$61.24
Total Value
$283.24K
Shares Held After
207,497
% of Holdings
2.2%
RESMED INC (RMD)
Rider Michael J — Global General Counsel
Shares
50
Price
$241.75
Total Value
$12.09K
Shares Held After
9,741
% of Holdings
0.5%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
3,150
Price
$22.84
Total Value
$71.95K
Shares Held After
91,996
% of Holdings
3.3%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Director
Shares
10,312
Price
$7.60
Total Value
$78.37K
Shares Held After
88,020
% of Holdings
10.5%
Xilio Therapeutics, Inc. (XLO)
Frankenfield Christopher James — Chief Financial Officer
Shares
7,030
Price
$0.64
Total Value
$4.52K
Shares Held After
24,766
% of Holdings
22.1%
ROCKWELL MEDICAL, INC. (RMTI)
Hunter Heather — Chief Operating Officer
Shares
2,868
Price
$0.84
Total Value
$2.40K
Shares Held After
132,523
% of Holdings
2.1%
ROCKWELL MEDICAL, INC. (RMTI)
Neri Jesse — SVP and CFO
Shares
886
Price
$0.84
Total Value
$740.25
Shares Held After
124,842
% of Holdings
0.7%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
22,000
Price
$5.93
Total Value
$130.38K
Shares Held After
1,166,391
% of Holdings
1.9%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
540
Price
$101.47
Total Value
$54.79K
Shares Held After
49,086
% of Holdings
1.1%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
5,455
Price
$100.77
Total Value
$549.70K
Shares Held After
49,626
% of Holdings
9.9%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
4,005
Price
$100.03
Total Value
$400.62K
Shares Held After
55,081
% of Holdings
6.8%
Xilio Therapeutics, Inc. (XLO)
Brennan Kevin M. — SVP, FINANCE AND ACCOUNTING
Shares
1,826
Price
$0.64
Total Value
$1.17K
Shares Held After
6,371
% of Holdings
22.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$489.15
Total Value
$97.83K
Shares Held After
36,781
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,181
Price
$487.76
Total Value
$1.06M
Shares Held After
36,981
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,130
Price
$486.85
Total Value
$550.14K
Shares Held After
39,162
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,509
Price
$485.68
Total Value
$732.89K
Shares Held After
40,292
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,240
Price
$484.54
Total Value
$600.82K
Shares Held After
41,801
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
739
Price
$483.35
Total Value
$357.20K
Shares Held After
43,041
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
479
Price
$481.83
Total Value
$230.80K
Shares Held After
43,780
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
822
Price
$481.26
Total Value
$395.60K
Shares Held After
44,259
% of Holdings
1.8%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
4,015
Price
$5.73
Total Value
$23.01K
Shares Held After
766,480
% of Holdings
0.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
18,568
Price
$0.63
Total Value
$11.70K
Shares Held After
2,472,297
% of Holdings
0.7%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
885
Price
$63.16
Total Value
$55.90K
Shares Held After
50,440
% of Holdings
1.7%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
2,062
Price
$44.93
Total Value
$92.65K
Shares Held After
6,000
% of Holdings
25.6%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
37,938
Price
$44.40
Total Value
$1.68M
Shares Held After
8,062
% of Holdings
82.5%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
1,108
Price
$29.75
Total Value
$32.97K
Shares Held After
205,084
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
3,144
Price
$29.08
Total Value
$91.43K
Shares Held After
206,192
% of Holdings
1.5%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
8,748
Price
$28.17
Total Value
$246.40K
Shares Held After
209,336
% of Holdings
4.0%
Aveanna Healthcare Holdings, Inc. (AVAH)
Buckhalter Matthew — Chief Financial Officer
Shares
18,340
Price
$7.85
Total Value
$143.88K
Shares Held After
436,980
% of Holdings
4.0%
Aveanna Healthcare Holdings, Inc. (AVAH)
Stewart Deborah — SVP, Chief Accounting Officer
Shares
11,962
Price
$7.85
Total Value
$93.84K
Shares Held After
251,676
% of Holdings
4.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
Shaner Jeff — Chief Executive Officer
Shares
29,357
Price
$7.85
Total Value
$230.31K
Shares Held After
2,394,179
% of Holdings
1.2%
Aveanna Healthcare Holdings, Inc. (AVAH)
Reisz Edwin C. — Chief Administrative Officer
Shares
17,613
Price
$7.85
Total Value
$138.18K
Shares Held After
1,321,114
% of Holdings
1.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
Cunningham Patrick A. — Chief Compliance Officer
Shares
12,445
Price
$7.85
Total Value
$97.63K
Shares Held After
293,354
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
1,000
Price
$500.01
Total Value
$500.01K
Shares Held After
4,190
% of Holdings
19.3%
JOINT Corp (JYNT)
JOBSON CHARLES E — 10% Owner
Shares
1,393
Price
$8.70
Total Value
$12.12K
Shares Held After
1,616,431
% of Holdings
0.1%
Beta Bionics, Inc. (BBNX)
Feider Stephen — Chief Financial Officer
Shares
20,000
Price
$29.53
Total Value
$590.68K
Shares Held After
42,614
% of Holdings
31.9%
Showing 1451–1500 of 1606 transactions (page 30 of 33)